UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development and Validation of HPLC-UV Method for the Determination of Favipiravir in Human Plasma

Razrabotka i registraciâ lekarstvennyh sredstv (Online), 2022-09, Vol.11 (3), p.220-229

2022

Volltextzugriff (PDF)

CORRIGENDUM: “EVALUATION OF WEIGHT REDUCTION EFFICACY AND SAFETY OF SIBUTRAMIN-CONTAINING DRUGS IN PATIENTS WITH ALIMENTARY OBESITY”

Farmaciâ i Farmakologiâ (Pâtigorsk), 2022-10, Vol.10 (4), p.400

2022

Volltextzugriff (PDF)

EVALUATION OF WEIGHT REDUCTION EFFICACY AND SAFETY OF SIBUTRAMIN-CONTAINING DRUGS IN PATIENTS WITH ALIMENTARY OBESITY

Farmaciâ i Farmakologiâ (Pâtigorsk), 2022-07, Vol.10 (3), p.289-304

2022

Volltextzugriff (PDF)

CURRENT ASPECTS OF ETIOTROPIC COVID-19 THERAPY

Farmaciâ i Farmakologiâ (Pâtigorsk), 2022-01, Vol.10 (5), p.432-445

2022

Volltextzugriff (PDF)

STUDY OF LONG-TERM CLINICAL AND PATHOGENETIC EFFECTS OF FAVIPIRAVIR-BASED ANTI-VIRAL DRUG IN PATIENTS WITH METABOLIC SYNDROME IN POST-COVID PERIOD

Farmaciâ i Farmakologiâ (Pâtigorsk), 2022-01, Vol.10 (2), p.217-228

2022

Volltextzugriff (PDF)

MODERN DIRECTED ANTIVIRAL COVID-19 THERAPY: RESULTS OF MULTICENTER CLINICAL EFFECTIVENESS AND SAFETY STUDY OF FIXED NIRMATRELVIR+RITONAVIR COMBINATION

Farmaciâ i Farmakologiâ (Pâtigorsk), 2022-01, Vol.10 (4), p.371-386

2022

Volltextzugriff (PDF)

EFFICACY AND SAFETY OF ORIGINAL DRUG BASED ON HEXAPEPTIDE SUCCINATE IN COMPLEX COVID-19 THERAPY IN ADULTS HOSPITALIZED PATIENTS

Farmaciâ i Farmakologiâ (Pâtigorsk), 2022-01, Vol.10 (6), p.573-588

2022

Volltextzugriff (PDF)

Prospects and possibilities for the treatment of patients with long COVID-19 syndrome

Terapevtic̆eskii arhiv, 2022-12, Vol.94 (11), p.1285-1293

2022

Volltextzugriff (PDF)

Phase I Pharmacokinetics Study of Oral Administration of Esperavir® (INN: Molnupiravir) (LLC "PROMOMED RUS", Russia)

Razrabotka i registraciâ lekarstvennyh sredstv (Online), 2024-02, Vol.13 (1), p.216-223

2024

Volltextzugriff (PDF)

Phase I Pharmacokinetics Study of Drug for Infusion «Areplivir» (INN: Favipiravir) (LLC "PROMOMED RUS", Russia)

Razrabotka i registraciâ lekarstvennyh sredstv (Online), 2023-05, Vol.12 (2), p.146-153

2023

Volltextzugriff (PDF)

ACAROSPORA FUSCATA AND A. UMBILICATA (ACAROSPORACEAE, ASCOMYCOTA) IN BELARUS

Botanic̆eskij z̆urnal, 2022, Vol.107 (1), p.38-46

2022

Volltextzugriff (PDF)

Determination of Favipiravir in Human Blood Plasma by HPLC-MS/MS

Razrabotka i registraciâ lekarstvennyh sredstv (Online), 2023-09, Vol.12 (3), p.229-239

2023

Volltextzugriff (PDF)

Phase I Pharmacokinetics Study of Drug Areplivir® Zinc (INN: Favipiravir + Zinc Gluconate) (LLC "PROMOMED RUS", Russia)

Razrabotka i registraciâ lekarstvennyh sredstv (Online), 2024-02, Vol.13 (1), p.281-290

2024

Volltextzugriff (PDF)

Reciprocal Impact of Molnupiravir and Favipiravir Monocomponents of the Combination Drug on Each Other's Pharmacokinetics in a Phase I Clinical Trial

Razrabotka i registraciâ lekarstvennyh sredstv (Online), 2024-02, Vol.13 (1), p.272-280

2024

Volltextzugriff (PDF)

Study of the resistome of human microbial communities using a targeted panel of antibiotic resistance genes in COVID-19 patients

Terapevtic̆eskii arhiv, 2023-12, Vol.95 (12), p.1103-1111

2023

Volltextzugriff (PDF)

Simultaneous Determination of Nirmatrelvir and Ritonavir in Human Plasma by HPLC-MS/MS

Razrabotka i registraciâ lekarstvennyh sredstv (Online), 2023-05, Vol.12 (2), p.135-145

2023

Volltextzugriff (PDF)

Simultaneous Determination of Major Molnupiravir Metabolite (β-D-N4-hydroxycytidine) and Favipiravir in Human Plasma by HPLC-MS/MS

Razrabotka i registraciâ lekarstvennyh sredstv (Online), 2023-02, Vol.12 (1), p.215-226

2023

Volltextzugriff (PDF)

Russian development for drug independence in endocrinology: comparative analysis of bioequivalence, safety and tolerability of the first domestic liraglutide

Farmaciâ i Farmakologiâ (Pâtigorsk), 2023-11, Vol.11 (3), p.255-276

2023

Volltextzugriff (PDF)

Analysis of cytokine response characteristics and immunopathogenetic effects of double-stranded sodium salt RNA-based drug for postexposure prophylaxis against novel coronavirus infection: double-blind, placebo-controlled trial

Farmaciâ i Farmakologiâ (Pâtigorsk), 2023-08, Vol.11 (2), p.137-148

2023

Volltextzugriff (PDF)

Genotypic features the response of the antioxidant complex of blueberry fruits (Vaccinium corymbosum L.) to the use of mineral and organic fertilizers on lowland peatland

Proceedings of the National Academy of Sciences of Belarus, Biological Series, 2022-02, Vol.67 (1), p.24-32

2022

Volltextzugriff (PDF)

Evaluation of the dynamics of oral pathogenic microbiota in COVID-19 patients by genomic sequencing after application of foam with antimicrobial action

Medical alphabet, 2024-05 (11), p.7-13

2024

Volltextzugriff (PDF)

Post-exposure prophylaxis of COVID-19: results of double-blind, placebo-controlled, multicenter clinical study evaluation of efficacy and safety of double-stranded sodium salt RNA drug

Farmaciâ i Farmakologiâ (Pâtigorsk), 2023-01, Vol.11 (1), p.72-88

2023

Volltextzugriff (PDF)

Comparative analysis of physicochemical properties, bioequivalence, safety and tolerability of the first domestic semaglutide

Farmaciâ i Farmakologiâ (Pâtigorsk), 2023-01, Vol.11 (4), p.324-346

2023

Volltextzugriff (PDF)

The imaging performance of the Hubble Space Telescope

The Astrophysical journal, 1991-03, Vol.369 (2), p.L21-L25

1991

Volltextzugriff (PDF)

Distribution of varieties of the lichen Pseudevernia furfuracea (Parmeliaceae) in Belarus

Vestnik of Orenburg State Pedagogical University. Electronic Scientific Journal, 2020 (35), p.85-95

2020

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Development and Validation of HPLC-UV Method for the Determination of Favipiravir in Human Plasma

CORRIGENDUM: “EVALUATION OF WEIGHT REDUCTION EFFICACY AND SAFETY OF SIBUTRAMIN-CONTAINING DRUGS IN PATIENTS WITH ALIMENTARY OBESITY”

EVALUATION OF WEIGHT REDUCTION EFFICACY AND SAFETY OF SIBUTRAMIN-CONTAINING DRUGS IN PATIENTS WITH ALIMENTARY OBESITY

CURRENT ASPECTS OF ETIOTROPIC COVID-19 THERAPY

STUDY OF LONG-TERM CLINICAL AND PATHOGENETIC EFFECTS OF FAVIPIRAVIR-BASED ANTI-VIRAL DRUG IN PATIENTS WITH METABOLIC SYNDROME IN POST-COVID PERIOD

MODERN DIRECTED ANTIVIRAL COVID-19 THERAPY: RESULTS OF MULTICENTER CLINICAL EFFECTIVENESS AND SAFETY STUDY OF FIXED NIRMATRELVIR+RITONAVIR COMBINATION

EFFICACY AND SAFETY OF ORIGINAL DRUG BASED ON HEXAPEPTIDE SUCCINATE IN COMPLEX COVID-19 THERAPY IN ADULTS HOSPITALIZED PATIENTS

Prospects and possibilities for the treatment of patients with long COVID-19 syndrome

Phase I Pharmacokinetics Study of Oral Administration of Esperavir® (INN: Molnupiravir) (LLC "PROMOMED RUS", Russia)

Phase I Pharmacokinetics Study of Drug for Infusion «Areplivir» (INN: Favipiravir) (LLC "PROMOMED RUS", Russia)

ACAROSPORA FUSCATA AND A. UMBILICATA (ACAROSPORACEAE, ASCOMYCOTA) IN BELARUS

Determination of Favipiravir in Human Blood Plasma by HPLC-MS/MS

Phase I Pharmacokinetics Study of Drug Areplivir® Zinc (INN: Favipiravir + Zinc Gluconate) (LLC "PROMOMED RUS", Russia)

Reciprocal Impact of Molnupiravir and Favipiravir Monocomponents of the Combination Drug on Each Other's Pharmacokinetics in a Phase I Clinical Trial

Study of the resistome of human microbial communities using a targeted panel of antibiotic resistance genes in COVID-19 patients

Simultaneous Determination of Nirmatrelvir and Ritonavir in Human Plasma by HPLC-MS/MS

Simultaneous Determination of Major Molnupiravir Metabolite (β-D-N4-hydroxycytidine) and Favipiravir in Human Plasma by HPLC-MS/MS

Russian development for drug independence in endocrinology: comparative analysis of bioequivalence, safety and tolerability of the first domestic liraglutide

Analysis of cytokine response characteristics and immunopathogenetic effects of double-stranded sodium salt RNA-based drug for postexposure prophylaxis against novel coronavirus infection: double-blind, placebo-controlled trial

Genotypic features the response of the antioxidant complex of blueberry fruits (Vaccinium corymbosum L.) to the use of mineral and organic fertilizers on lowland peatland

Evaluation of the dynamics of oral pathogenic microbiota in COVID-19 patients by genomic sequencing after application of foam with antimicrobial action

Post-exposure prophylaxis of COVID-19: results of double-blind, placebo-controlled, multicenter clinical study evaluation of efficacy and safety of double-stranded sodium salt RNA drug

Comparative analysis of physicochemical properties, bioequivalence, safety and tolerability of the first domestic semaglutide

The imaging performance of the Hubble Space Telescope

Distribution of varieties of the lichen Pseudevernia furfuracea (Parmeliaceae) in Belarus

Suchergebnisse filtern